CD14 and myeloproliferative disorder: Monocytes, whether classical (CD14+ CD16−), non-classical (CD14− CD16+) or intermediate (CD14+ CD16+), represent key cellular mediators of inflammation, thrombosis and BM fibrosis, contributing to MPN pathogenesis through multifaceted mechanisms.